Case File
efta-01371273DOJ Data Set 10OtherEFTA01371273
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01371273
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
Successful Healthcare Operational Track Record
Alvarado Hospital Medical Center (2006 - 2010)
Investment Summary
Investment Returns
Acquisition date
Seller
Dec-2006
tenet
Exit date
Buyer
Nov-2010
a Prime I lealthcare
Purchase price
$22 million
Location
San Diego, CA
Equity multiple!'?
6.0x
Hospital type
Acute & specialty care
IRR
-50%
# Beds
# Employees
306
1,500+
Additional real
estate development
4.0x on additional equity
Clinical Improvement Highlights
— Physician recruitment: Cardiology, orthopedics, spine program,
neurosurgery, urology and internal medicine
- New specialties and service lines: Minimally invasive spine surgery
program, skull base neurosurgery program and laparoscopic gastric bypass
adding a new MRI suite, new CT scan suite, and new cardiac
catheterization suite
Increased patient census: With the new specialties and service lines, an
emergency room physician restructuring, and improved hospital admissions
Operational Improvement Highlights
— Health insurance plan reimbursements: Renegotiated health plan
agreements achieving significant rate increases
— Navigate regulatory environment: Renegotiated Medicaid and CDCR
agreements with the State of California achieving significant rate increases
— Operating Improvements: Hospitalist program implemented to reduce
patient length-of-stay and hospital acquired infections, and renegotiated
vendor agreements achieving significant cost savings.
— Development of Excess Real Estate: Built 320 student housing units on
half the 10-acre hospital campus, which is next to San Diego State
University
Clinical Achievements
Financial Achievements
Emergency department admissions growth
+22%
Average daily census growth
From 80 to 120
Hospital admissions growth
+55%
Length of stay reduction
From 7.4 to 4.2 days
Cardiac admissions growth
+88%
Revenue growth
14% CAGR from $120mm to $200mm
Clinical trials growth
From 1 to 55
EBITDA turnaround
($10mm) loss to $12mm profit
(a)
Represents the total amount of equity returned over the total amount of equity invested
American Medical Properties
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e)
DB-SDNY-0064564
CONFIDENTIAL
SDNY_GM_00210748
EFTA01371273
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.